139 related articles for article (PubMed ID: 17889580)
41. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
[TBL] [Abstract][Full Text] [Related]
42. Effects on the reactive oxygen species of erdosteine and its metabolite in vitro.
Hosoe H; Kaise T; Ohmori K
Arzneimittelforschung; 2002; 52(6):435-40. PubMed ID: 12109043
[TBL] [Abstract][Full Text] [Related]
43. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
[TBL] [Abstract][Full Text] [Related]
44. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.
Yildirim Z; Turkoz Y; Kotuk M; Armutcu F; Gurel A; Iraz M; Ozen S; Aydogdu I; Akyol O
Nitric Oxide; 2004 Sep; 11(2):156-65. PubMed ID: 15491848
[TBL] [Abstract][Full Text] [Related]
45. [The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease].
Wan P; Zhong XN; He ZY; Zhang JQ; Liu GN; Lao QF
Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):841-5. PubMed ID: 20079227
[TBL] [Abstract][Full Text] [Related]
46. Airway epithelial inflammatory responses and clinical parameters in COPD.
Patel IS; Roberts NJ; Lloyd-Owen SJ; Sapsford RJ; Wedzicha JA
Eur Respir J; 2003 Jul; 22(1):94-9. PubMed ID: 12882457
[TBL] [Abstract][Full Text] [Related]
47. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
[TBL] [Abstract][Full Text] [Related]
48. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease.
Rusznak C; Mills PR; Devalia JL; Sapsford RJ; Davies RJ; Lozewicz S
Am J Respir Cell Mol Biol; 2000 Oct; 23(4):530-6. PubMed ID: 11017919
[TBL] [Abstract][Full Text] [Related]
49. The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats.
Ozerol E; Bilgic S; Iraz M; Cigli A; Ilhan A; Akyol O
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):20-4. PubMed ID: 18930779
[TBL] [Abstract][Full Text] [Related]
50. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
51. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys).
Carpagnano GE; Resta O; Foschino-Barbaro MP; Spanevello A; Stefano A; Di Gioia G; Serviddio G; Gramiccioni E
Eur J Pharmacol; 2004 Nov; 505(1-3):169-75. PubMed ID: 15556150
[TBL] [Abstract][Full Text] [Related]
52. Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease.
Xue T; Wei N; Xin Z; Qingyu X
Inhal Toxicol; 2014 Jan; 26(1):14-22. PubMed ID: 24417403
[TBL] [Abstract][Full Text] [Related]
53. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children.
Balli F; Bergamini B; Calistru P; Ciofu EP; Domenici R; Doros G; Dragomir D; Gherghina I; Iordachescu F; Murgoci G; Orasanu D; Plesca D; Vaccaro A; Assereto R
Int J Clin Pharmacol Ther; 2007 Jan; 45(1):16-22. PubMed ID: 17256446
[TBL] [Abstract][Full Text] [Related]
54. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease.
Ricciardolo FL; Caramori G; Ito K; Capelli A; Brun P; Abatangelo G; Papi A; Chung KF; Adcock I; Barnes PJ; Donner CF; Rossi A; Di Stefano A
J Allergy Clin Immunol; 2005 Nov; 116(5):1028-35. PubMed ID: 16275371
[TBL] [Abstract][Full Text] [Related]
55. Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokers.
Koczulla AR; Noeske S; Herr C; Jörres RA; Römmelt H; Vogelmeier C; Bals R
Respiration; 2010; 79(1):61-7. PubMed ID: 19816000
[TBL] [Abstract][Full Text] [Related]
56. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
Milara J; Peiró T; Serrano A; Guijarro R; Zaragozá C; Tenor H; Cortijo J
Pulm Pharmacol Ther; 2014 Aug; 28(2):138-48. PubMed ID: 24525294
[TBL] [Abstract][Full Text] [Related]
57. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
58. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
59. Protection of erdosteine on smoke-induced peripheral neutrophil dysfunction both in healthy and in bronchitic smokers.
Ciaccia A; Papi A; Tschirky B; Fregnan B
Fundam Clin Pharmacol; 1992; 6(8-9):375-82. PubMed ID: 1292969
[TBL] [Abstract][Full Text] [Related]
60. Regulation of sepsis-induced apoptosis of pulmonary cells by posttreatment of erdosteine and N-aceylcysteine.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Dec; 228(2-3):151-61. PubMed ID: 17046137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
